ReviewAnnals of medicine and surgery (2012)2026
Unveiling the landscape of vancomycin in periprosthetic joint infections: a comprehensive bibliometric analysis.
Review in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Periprosthetic joint infection (PJI) is a devastating adverse complication after joint replacement surgery. Vancomycin is crucial in treating PJI but presents unique challenges. Despite extensive research, a comprehensive bibliometric analysis is missing. This study aims to identify key contributors, evaluate current research, and highlight major scientific issues. Methods: We retrieved studies on vancomycin and PJI from the Web of Science Core Collection database, gathering data on publications, authors, citations, publication year, H-index, references, country/region, journal, and keywords. Bibliometric and visual analyses were conducted using R-bibliometrix, VOSviewer, and CiteSpace. Results: The analysis included 451 publications from 725 institutions in 43 countries/regions from 2010 to 2025, showing a clear growth trend in annual publications. The United States contributed the most (172, 39.2%), with the Mayo Clinic leading in studies (28, 6.21%). Cao L had the highest number of publications, while Parvizi J received the most citations. The Journal of Arthroplasty was the leading journal in this field. Current research on vancomycin in PJI focuses on improving localized application and new drug delivery systems to tackle biofilm infections and antibiotic resistance. Additionally, burden management has emerged as a significant research area. Conclusion: This study summarizes publications characteristics and identifies influential countries, institutions, authors, journals, and trends related to vancomycin use in PJI. The findings offer researchers valuable insights and help clinicians improve diagnostic and therapeutic services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.